# Intravenous Stable Isotope Glycerol for Clinical Research

Canonical: https://abierto.us/opportunities/75n98026q00598

- Solicitation number: 75N98026Q00598
- Notice type: Presolicitation
- Status: Closed. Deadline was June 11, 2026 at 9:00 AM EDT
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Olao (75N980)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6810 Chemicals
- Set-aside: 8(a) set-aside
- Place of performance: Bethesda, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Bethesda. https://abierto.us/cities/bethesda-md-2407125
- First posted: June 11, 2026
- Last posted: June 11, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/916d3dd15c5c40028f0deb8bf1ab7651/view

## Description

The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.

Stable isotopes have been used safely in clinical research for decades and have contributed seminal insights into human metabolism. In many cases, stable isotopes allow for the generation of knowledge that may not be possible by any other method.

Under the directive of the National Institutes of Health (NIH) Sterile Products for Human Administration (SPHA) Executive Committee and the NIH Office of Research Support and Compliance (approved October 2021), stable isotopes used in human metabolic clinical studies must meet the outlined minimum requirements. This requirement, initiated on behalf of NIDDK principal investigators, is for intravenous stable isotope glycerol procurement.

The contractor shall be responsible for sourcing the raw material, packaging and/or manufacturing the isotope product, and submitting and releasing the product to the NIH Clinical Center Pharmacy following microbial and analytical testing.

## Publications

- June 11, 2026: Presolicitation, due June 11, 2026 at 9:00 AM EDT. Notice 916d3dd15c5c40028f0deb8bf1ab7651. https://sam.gov/workspace/contract/opp/916d3dd15c5c40028f0deb8bf1ab7651/view

## Points of contact

- LAW, JAMES B, james.law@nih.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n98026q00598.
